Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

As the SARS-CoV-2 pandemic remains uncontrolled owing to the continuous emergence of variants of concern, there is an immediate need to implement the most effective antiviral treatment strategies, especially for risk groups. Here, we evaluated the therapeutic potency of nirmatrelvir, remdesivir and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ju Hwan, Chokkakula, Santosh, Min, Seong Cheol, Kim, Beom Kyu, Choi, Won-Suk, Oh, Sol, Yun, Yu Soo, Kang, Da Hyeon, Lee, Ok-Jun, Kim, Eung-Gook, Choi, Jang-Hoon, Lee, Joo-Yeon, Choi, Young Ki, Baek, Yun Hee, Song, Min-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535923/
https://www.ncbi.nlm.nih.gov/pubmed/36209984
http://dx.doi.org/10.1016/j.antiviral.2022.105430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535923/
https://www.ncbi.nlm.nih.gov/pubmed/36209984
http://dx.doi.org/10.1016/j.antiviral.2022.105430

Ejemplares similares